Kyntra Bio Inc

KYNB

Healthcare Biotechnology

Kyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.

Revenue
n/m
EPS
n/m
Free cash flow
n/m

Quarter to June 2026, against a year earlier

3.44 0.15 −4.18%
Market cap
$14.5M
P/E
0.1×
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
5/9
ROIC
0.00%
Net debt / EBITDA
2.0×
Payout ratio
—

Kyntra Bio Inc (KYNB) Return on invested capital

Alert me on Return on invested capital

Kyntra Bio Inc's return on invested capital over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −360.7% (fiscal 2018) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.

Return on invested capital, annual

Embed this chart

Annual newest first

Period Return on invested capital Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 0.00
FY2020 0.00% 142.19
FY2019 −142.2% 218.48
FY2018 −360.7% (360.67)
FY2017 0.00% 162.20
FY2016 −162.2% (119.15)

Against its own ten years

Low −360.7% High 0.00%
Ten-year median 0.00%
Current reading's percentile 100

Return on invested capital against peers

Company Return on invested capital
NCEL NewcelX Ltd. compare 0.00%
QNTM Quantum Biopharma Ltd. compare 0.00%
ADAPY Adaptimmune Therapeutics PLC compare 0.00%
ALLR Allarity Therapeutics, Inc. compare 0.00%
KYNB Kyntra Bio Inc 0.00%
JSPR Jasper Therapeutics, Inc. compare 0.00%
CTXR Citius Pharmaceuticals, Inc. compare −58.7%
MRKR MARKER THERAPEUTICS, INC. compare −566.8%
MCRB Seres Therapeutics, Inc. compare −1,267.8%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on KYNB